Galderma Group AG (GALD) Stock Forecast & Price Target

Compare

8 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

GALD Analyst Ratings

Strong Buy

9 Buy

3 Hold

0 Sell

Based on 12 analysts giving stock ratings to

Galderma

Group AG

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

GALD Stock 12 Month Forecast

Average Price Target

CHF138.30

▲(8.47% Upside)

Based on 12 Wall Street analysts offering 12 month price targets for Galderma Group AG in the last 3 months. The average price target is CHF138.30 with a high forecast of CHF165.00 and a low forecast of CHF112.00. The average price target represents a 8.47% change from the last price of CHF127.50.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"76":"CHF76","121":"CHF121","166":"CHF166","98.5":"CHF98.5","143.5":"CHF143.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":165,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">CHF165.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":138.3,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">CHF138.30</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":112,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">CHF112.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[76,98.5,121,143.5,166],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Dec<br/>2024","6":"Feb<br/>2025","9":"May<br/>2025","12":"Aug<br/>2025","25":"Aug<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,127.5,130.3846153846154,133.26923076923077,136.15384615384616,139.03846153846155,141.92307692307693,144.80769230769232,147.69230769230768,150.57692307692307,153.46153846153845,156.34615384615384,159.23076923076923,162.1153846153846,{"y":165,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,127.5,128.33076923076922,129.16153846153847,129.9923076923077,130.82307692307694,131.65384615384616,132.48461538461538,133.31538461538463,134.14615384615385,134.97692307692307,135.80769230769232,136.63846153846154,137.4692307692308,{"y":138.3,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,127.5,126.3076923076923,125.11538461538461,123.92307692307692,122.73076923076923,121.53846153846153,120.34615384615384,119.15384615384616,117.96153846153847,116.76923076923077,115.57692307692308,114.38461538461539,113.1923076923077,{"y":112,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":80.76,"date":1725148800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":77.48,"date":1727740800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":81.3,"date":1730419200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":89.41,"date":1733011200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":100.47,"date":1735689600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":100.47,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":110.52,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":109.76,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":95.27,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":95.9,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":110.7,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":115.5,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":127.5,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price TargetCHF165.00

Average Price TargetCHF138.30

Lowest Price TargetCHF112.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

TipRanks AITipRanks

Not Ranked

TipRanks

CHF134

Buy

5.10%

Upside

07/08/25

Galderma Group AG's stock score is primarily driven by strong financial performance and positive technical indicators. However, the high P/E ratio and low dividend yield suggest potential overvaluation, which tempers the overall score.

Yihan LiBarclays

Barclays

CHF140

Buy

9.80%

Upside

Reiterated

08/04/25

Barclays Reaffirms Their Buy Rating on Galderma Group AG (GALD)

Bethan DaviesBerenberg Bank

Berenberg Bank

CHF165

Buy

29.41%

Upside

Reiterated

07/31/25

Galderma Group AG (GALD) Gets a Buy from Berenberg Bank

Alistair CampbellRBC Capital

RBC Capital

CHF114→CHF128

Hold

0.39%

Upside

Reiterated

07/30/25

RBC Capital Reaffirms Their Hold Rating on Galderma Group AG (GALD)

Thibault BoutherinMorgan Stanley

Morgan Stanley

CHF105→CHF135

Hold

5.88%

Upside

Reiterated

07/28/25

Morgan Stanley Sticks to Their Hold Rating for Galderma Group AG (GALD)We increase our PT from CHF 105 to CHF 135 driven by Nemluvio forecasts upgrade and recognition of the resilience and durability of the aesthetics and skincare businesses.

Matthew WestonUBS

UBS

CHF120→CHF138

Hold

8.24%

Upside

Reiterated

07/25/25

Galderma Group AG (GALD) Receives a Hold from UBS

James GordonJ.P. Morgan

J.P. Morgan

CHF120→CHF160

Buy

25.49%

Upside

Reiterated

07/25/25

J.P. Morgan Reaffirms Their Buy Rating on Galderma Group AG (GALD)JPMorgan analyst James Gordon raised the price target on Galderma Group AG (GALD:SW) to CHF160.00 (from CHF120.00) while maintaining a Overweight rating.

Cedric BesnardCiti

Citi

CHF140

Buy

9.80%

Upside

Reiterated

07/25/25

Citi Keeps Their Buy Rating on Galderma Group AG (GALD)

Justine TelliezKepler Capital

Kepler Capital

CHF137

Buy

7.45%

Upside

Reiterated

07/24/25

Kepler Capital Sticks to Its Buy Rating for Galderma Group AG (GALD)

Benjamin Jackson CFAJefferies

Jefferies

CHF112

Buy

-12.16%

Downside

Reiterated

07/24/25

Galderma Group AG: Strong First Half Performance and Upgraded Sales Outlook Justify Buy RatingWe are already slightly more optimistic than cons on Core EBITDA, partially down to improved mix on higher Nemluvio.

Unknown AnalystWilliam O'Neil

Not Ranked

William O'Neil

―

Buy

―

Initiated

07/09/25

Galderma Group AG (GALD) Has a New Rating from William O'Neil

Chris ShibutaniGoldman Sachs

Goldman Sachs

CHF112→CHF128

Buy

0.39%

Upside

Reiterated

07/07/25

Goldman Sachs Keeps Their Buy Rating on Galderma Group AG (GALD)

Unknown AnalystPeel Hunt

Not Ranked

Peel Hunt

―

Buy

―

Reiterated

06/30/25

Peter VerdultExane BNP Paribas

Exane BNP Paribas

CHF100

Buy

-21.57%

Downside

Initiated

04/16/25

BNP Paribas Exane Starts Galderma Group AG (GALD:SW) at OutperformBNP Paribas Exane analyst Peter Verdult initiates coverage on Galderma Group AG (GALD:SW) with a Outperform rating and a price target of CHF100.00.

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

TipRanks AITipRanks

Not Ranked

TipRanks

CHF134

Buy

5.10%

Upside

07/08/25

Yihan LiBarclays

Barclays

CHF140

Buy

9.80%

Upside

Reiterated

08/04/25

Barclays Reaffirms Their Buy Rating on Galderma Group AG (GALD)

Bethan DaviesBerenberg Bank

Berenberg Bank

CHF165

Buy

29.41%

Upside

Reiterated

07/31/25

Galderma Group AG (GALD) Gets a Buy from Berenberg Bank

Alistair CampbellRBC Capital

RBC Capital

CHF114→CHF128

Hold

0.39%

Upside

Reiterated

07/30/25

RBC Capital Reaffirms Their Hold Rating on Galderma Group AG (GALD)

Thibault BoutherinMorgan Stanley

Morgan Stanley

CHF105→CHF135

Hold

5.88%

Upside

Reiterated

07/28/25

Matthew WestonUBS

UBS

CHF120→CHF138

Hold

8.24%

Upside

Reiterated

07/25/25

Galderma Group AG (GALD) Receives a Hold from UBS

James GordonJ.P. Morgan

J.P. Morgan

CHF120→CHF160

Buy

25.49%

Upside

Reiterated

07/25/25

Cedric BesnardCiti

Citi

CHF140

Buy

9.80%

Upside

Reiterated

07/25/25

Citi Keeps Their Buy Rating on Galderma Group AG (GALD)

Justine TelliezKepler Capital

Kepler Capital

CHF137

Buy

7.45%

Upside

Reiterated

07/24/25

Kepler Capital Sticks to Its Buy Rating for Galderma Group AG (GALD)

Benjamin Jackson CFAJefferies

Jefferies

CHF112

Buy

-12.16%

Downside

Reiterated

07/24/25

Unknown AnalystWilliam O'Neil

Not Ranked

William O'Neil

―

Buy

―

Initiated

07/09/25

Galderma Group AG (GALD) Has a New Rating from William O'Neil

Chris ShibutaniGoldman Sachs

Goldman Sachs

CHF112→CHF128

Buy

0.39%

Upside

Reiterated

07/07/25

Goldman Sachs Keeps Their Buy Rating on Galderma Group AG (GALD)

Unknown AnalystPeel Hunt

Not Ranked

Peel Hunt

―

Buy

―

Reiterated

06/30/25

Peter VerdultExane BNP Paribas

Exane BNP Paribas

CHF100

Buy

-21.57%

Downside

Initiated

04/16/25

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Galderma Group AG

1 Month

xxx

Success Rate

4/5 ratings generated profit

Average Return

+9.02%

reiterated a xxx

rating 14 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 80.00% of your transactions generating a profit, with an average return of +9.02% per trade.

3 Months

xxx

Success Rate

5/5 ratings generated profit

Average Return

+29.12%

reiterated a xxx

rating 14 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +29.12% per trade.

1 Year

Chris ShibutaniGoldman Sachs

Success Rate

2/2 ratings generated profit

Average Return

+40.50%

reiterated a buy rating last month

Copying Chris Shibutani's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +40.50% per trade.

2 Years

xxx

Success Rate

5/5 ratings generated profit

Average Return

+32.84%

reiterated a xxx

rating 14 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +32.84% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

GALD Analyst Recommendation Trends

Rating

Apr 25

May 25

Jun 25

Jul 25

Aug 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, GALD has received 25 Buy Ratings, 5 Hold Ratings, and 0 Sell Ratings. GALD average Analyst price target in the past 3 months is 138.30.

Each month's total comprises the sum of three months' worth of ratings.

GALD Financial Forecast

GALD Earnings Forecast

Next quarter’s earnings estimate for GALD is CHF1.31 with a range of CHF1.24 to CHF1.38. The previous quarter’s EPS was CHF1.11. GALD beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.03% of the time in the same period. In the last calendar year GALD has Outperformed its overall industry.

GALD Sales Forecast

Next quarter’s sales forecast for GALD is CHF2.04B with a range of CHF2.02B to CHF2.07B. The previous quarter’s sales results were CHF2.11B. GALD beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 47.64% of the time in the same period. In the last calendar year GALD has Outperformed its overall industry.

GALD Stock Forecast FAQ

What is CH:GALD’s average 12-month price target, according to analysts?

Based on analyst ratings, Galderma Group AG’s 12-month average price target is 138.30.

What is CH:GALD’s upside potential, based on the analysts’ average price target?

Galderma Group AG has 8.47% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Galderma Group AG a Buy, Sell or Hold?

Galderma Group AG has a consensus rating of Strong Buy, which is based on 9 buy ratings, 3 hold ratings and 0 sell ratings.

What is Galderma Group AG’s share price target?

The average share price target for Galderma Group AG is 138.30. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is CHF165.00 ,and the lowest forecast is CHF112.00. The average share price target represents 8.47% Increase from the current price of CHF127.5.

What do analysts say about Galderma Group AG?

Galderma Group AG’s analyst rating consensus is a Strong Buy. This is based on the ratings of 12 Wall Streets Analysts.

How can I buy shares of Galderma Group AG?

To buy shares of CH:GALD, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Galderma Group AG (GALD) Stock Forecast & Price Target

GALD Analyst Ratings

GALD Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Galderma Group AG

GALD Analyst Recommendation Trends

GALD Financial Forecast

GALD Earnings Forecast

GALD Sales Forecast

GALD Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts